ThinkEquity Downgrades Navidea Biopharmaceuticals (NAVB) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. TFII
6. LYB
7. LITE
8. NVT
9. SPY
10. AAPL

Go back to ThinkEquity Downgrades Navidea Biopharmaceuticals (NAVB) to Hold

Navidea Biopharma (NAVB) Gets CRL from FDA for Lymphoseek NDA

September 10, 2012 4:02 PM EDT

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Lymphoseek (technetium Tc 99m tilmanocept) Injection. In the CRL, the FDA noted the decision... More